Radionuclide Evaluation of Pleural–Peritoneal Shunt Before PleurodesisDias, Kerri, MD*; Raja, Shanker, MD†; Strane, Timothy, RPh, BCNP†; Sane, Shekhar, MD*Clinical Nuclear Medicine: September 2004 - Volume 29 - Issue 9 - p 545-547 doi: 10.1097/01.rlu.0000134980.57598.5d Original Article Buy Abstract Author InformationAuthors Article MetricsMetrics Objectives: Talc pleurodesis can be offered to patients with hepatic hydrothorax. The authors wanted to determine their patient's eligibility for talc pleurodesis by excluding a pleural–peritoneal shunt. Materials and Methods: The authors measured the size of the talc particles and matched them with the radionuclide particle size. After injecting radiopharmaceutical into the pleura, the authors imaged the abdomen for possible migration. Results: In their patient, there was no migration of radionuclide from the thorax into the abdomen. Conclusion: Injecting radionuclide into the thoracic cavity and then imaging for an extended period of time is one way to determine whether the patient has a pleural–peritoneal shunt. From the *Department of Radiology and the †Department of Nuclear Medicine, St. Luke's Medical Center, Milwaukee, Wisconsin. Received for publication February 27, 2004; accepted April 12, 2004. Reprints: Kerri Dias, MD, St. Luke's Medical Center, Department of Radiology, 2900 West Oklahoma Avenue, Milwaukee, WI 53215. E-mail: firstname.lastname@example.org © 2004 Lippincott Williams & Wilkins, Inc.